DEC 18, 2020 5:00 AM PST

A new approach of COVID-19 surveillance testing to maximize the identification of asymptomatic patients

Sponsored by: DiaSorin
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Associate Professor and Head of the Unit of Microbiology The Greater Romagna Area Hub Laboratory DIMES - University of Bologna
    BIOGRAPHY

Abstract

Date:  December 18, 2020

Time: 5:00am PST, 2:00pm CET

 

Europe continues to battle a second wave of COVID19 epidemic; more than 30.000 newly infected patients are being confirmed daily in Italy. As of November 16th, 27,687 individuals have been infected with SARS-CoV-2 in Italy, of whom 600 have passed away. The World Health Organization (WHO) has raised a global warning and announced the need for a test system for COVID-19- suspected patients (World Health Organization, 2020). SARS-CoV-2 is known to be spread even by infected people who experience only mild symptoms or are asymptomatic carriers (Li etal.,2020;Baietal., 2020; Rothe et al., 2020). Therefore, there is a need to expand testing capacity also to asymptomatic individuals to stop transmission. In routine clinical practice, SARS-CoV-2 infection is determined by reverse-transcription PCR (RT-PCR) analysis (Corman et al., 2020). The RT-PCR test is conducted using different types of specimens, including sputum, nasopharyngeal swabs, pharyngeal swabs, saliva, stool, bronchoalveolar lavage fluid, and endotracheal aspirate fluid (KK-W et al., 2020; To et al., 2020; Wang et al., 2020). However, the RT-PCR test is not rapid (it typically takes 3–4 h for results), and it requires specialized laboratory equipment and skilled technicians, while antigen tests are simple and can be performed routinely in clinical laboratories (Lai et al., 2020; Clerc and Greub, 2010). New more cost-effective and high throughput test system will be important for preventing viral spread and monitoring infection levels in COVID-19 patients. Here, we are presenting a newly approach of Covid-19 testing that will be used as a filter, by identifying, isolating, and thus filtering out currently infected persons, including those who are asymptomatic. This is a new regimen of testing to detect frequently the asymptomatic infected persons, which are primary source of transmission.

 

Learning Objectives:

  • To assess the use of Antigen assay in screening of asymptomatic COVID-19 individuals
  • To demonstrate the impact of a new regimen of COVID-19 testing
  • To evaluate whether the new screening approach is cost-effective

 

 

Webinars will be available for unlimited on-demand viewing after live event.

 

LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.


Show Resources
You May Also Like
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
JUN 29, 2022 8:00 AM PDT
JUN 29, 2022 8:00 AM PDT
Date: June 29, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CEST) As of May 2022, there have been more than 500 million confirmed cases of COVID-19, including numerous variants. Additiona...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
JAN 13, 2022 9:00 AM PST
C.E. CREDITS
JAN 13, 2022 9:00 AM PST
Date: January 13, 2022 Time: 09:00am (PST), 12:00pm (EST) Recently, the Infectious Disease Society of America released guidance on how to approach treatment of infections caused by multidrug...
FEB 24, 2022 10:00 AM PST
C.E. CREDITS
FEB 24, 2022 10:00 AM PST
Date: February 24, 2021 Time: 10:00am (PST), 1:00pm (EST) One of the largest global public health crises is the rise of antimicrobial-resistant infections. Globally, over 700,000 people die...
DEC 18, 2020 5:00 AM PST

A new approach of COVID-19 surveillance testing to maximize the identification of asymptomatic patients

Sponsored by: DiaSorin
C.E. Credits: P.A.C.E. CE Florida CE


Show Resources
Loading Comments...
Show Resources